Skip to content
HowShorted

CorMedix Inc. short interest in 2023

In 2023, CorMedix Inc.'s disclosed short interest ran from 3.98% of shares outstanding on 13 Jan 2023 to 12.94% on 29 Dec 2023, a change of +8.96 percentage points. The year's high was 14.28% on 30 Nov 2023 and its low 3.89% on 28 Feb 2023, averaging 7.89% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.07 days on 29 Dec 2023. Full history: CorMedix Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CorMedix Inc. in 2023

2023 in figures

Start of year
3.98% (13 Jan 2023)
End of year
12.94% (29 Dec 2023)
Change
+8.96 pp
High
14.28% (30 Nov 2023)
Low
3.89% (28 Feb 2023)
Average
7.89%
Highest days to cover
14.07 (29 Dec 2023)
SEC filings marked
8

Every report in 2023

CorMedix Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20233.98%6.32
31 Jan 20234.02%6.39
15 Feb 20233.90%8.45
28 Feb 20233.89%7.90
15 Mar 20234.04%6.98
31 Mar 20234.47%8.8410-K filed, results (8-K)
14 Apr 20234.62%5.39
28 Apr 20234.98%6.62
15 May 20234.89%8.1810-Q filed, results (8-K)
31 May 20235.88%6.04
15 Jun 20236.82%7.28
30 Jun 202311.74%2.87
14 Jul 202311.72%5.33
31 Jul 20239.80%7.05
15 Aug 20237.35%8.5310-Q filed, results (8-K)
31 Aug 20237.37%11.41
15 Sep 20238.51%7.44
29 Sep 20239.05%11.19
13 Oct 20239.33%12.56
31 Oct 202310.39%11.86
15 Nov 202312.15%3.4510-Q filed, results (8-K)
30 Nov 202314.28%6.78
15 Dec 202313.13%12.00
29 Dec 202312.94%14.07

See also: CorMedix Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.